Clinical Associate Professor
University of British Columbia
University of British Columbia, Canada
Bayer (Speaker/Honoraria includes speakers bureau, symposia, and expert witness, Consultant/Advisory Board)Ferring (Speaker/Honoraria includes speakers bureau, symposia, and expert witness)Janssen (Speaker/Honoraria includes speakers bureau, symposia, and expert witness, Consultant/Advisory Board, Research Grant includes principal investigator, collaborator or consultant and pending grants as well as grants already received)Pfizer (Speaker/Honoraria includes speakers bureau, symposia, and expert witness, Consultant/Advisory Board, Research Grant includes principal investigator, collaborator or consultant and pending grants as well as grants already received)
Margot Davis is a cardiologist at Vancouver General Hospital and St. Paul’s Hospital, a Clinical Associate Professor at the University of British Columbia, and Director of the UBC Cardiology-Oncology Program. She completed fellowships in Advanced Heart Failure & Transplant Cardiology and Cardio-Oncology & Cardiac Amyloidosis at Stanford University School of Medicine. She obtained her Master of Science degree in clinical epidemiology at the Harvard School of Public Health.
Dr. Davis is Co-Chair of the CCS/CHFS Position Statement on Cardiac Amyloidosis, a Primary Panel member of the CCS Cardio-Oncology Guidelines, and a Secondary Panel member of the CCS Heart Failure Guidelines. She is on the Executive Committee of the Canadian Heart Failure Society Board of Directors and she is Vice President of the Canadian Cardiac Oncology Network. Her research interests are focused on the prevention, diagnosis, and management of heart disease related to cancer therapy, cardiac amyloidosis, and advanced heart failure.